Comparison of twin-block and dynamax appliances for the treatment of class II malocclusion in adolescents: A randomized controlled trial

American Journal of Orthodontics and Dentofacial Orthopedics

Volumn 138, Issue 2, 2010, Pages 144.e1-144.e9

  Thiruvenkatachari, Badri ^a   Sandler, Jonathan ^b   Murray, Alison ^c   Walsh, Tanya ^a   O'Brien, Kevin ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHESTERFIELD ROYAL HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955478880     PISSN: 08895406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajodo.2010.01.025     Document Type: Article

References (21)

1. N.M. Bass, and A. Bass The Dynamax system: a new orthopedic appliance J Clin Orthod 37 2003 268 277
2. R.T. Lee, C.S. Kyi, and G.J. Mack A controlled clinical trial of the effects of the Twin Block and Dynamax appliances on the hard and soft tissues Eur J Orthod 29 2007 272 282
3. K. O'Brien, J. Wright, F. Conboy, Y. Sanjie, N. Mandall, and S. Chadwick Effectiveness of treatment for Class II malocclusion with the Herbst or Twin-block appliances: a randomized, controlled trial Am J Orthod Dentofacial Orthop 124 2003 128 137
4. Medical Research Council. MRC guidelines for good clinical practice in clinical trials. Available at: http://open.mrc.gm/GCP/Documents/MRC-GCP- Guidelines.pdf. Accessed on May 1, 2009.
5. P.C. O'Brien, and T.R. Fleming A multiple testing procedure for clinical trials Biometrics 35 1979 549 556
6. S. McDonagh, J.P. Moss, P. Goodwin, and R.T. Lee A prospective optical surface scanning and cephalometric assessment of the effect of functional appliances on the soft tissues Eur J Orthod 23 2001 115 126
7. F. Trotta, G. Apolone, S. Garattini, and G. Tafuri Stopping a trial early in oncology: for patients or for industry? Ann Oncol 19 2008 1347 1353
8. P.S. Mueller, V.M. Montori, D. Bassler, B.A. Koenig, and G.H. Guyatt Ethical issues in stopping randomized trials early because of apparent benefit Ann Intern Med 146 2007 878 881
9. E. Mills, C. Cooper, P. Wu, B. Rachlis, S. Singh, and G.H. Guyatt Randomized trials stopped early for harm in HIV/AIDS: a systematic survey HIV Clin Trials 7 2006 24 33
10. K. Dickersin How important is publication bias? A synthesis of available data AIDS Educ Prev 9 1997 15 21
11. H. Aladdin, H. Ullum, T. Katzenstein, J. Gerstoft, P. Skinhoj, and B. Klarlund Pedersen Immunological and virological changes in antiretroviral naive human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART Scand J Immunol 51 2000 520 525
12. G.L. Anderson, C. Kooperberg, N. Geller, J.E. Rossouw, M. Pettinger, and R.L. Prentice Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials Clin Trials 4 2007 207 217
13. D.H. Blanckenberg, R. Wood, A. Horban, M. Beniowski, A. Boron-Kaczmarska, and H. Trocha Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects Aids 18 2004 631 640
14. D.L. Cohn, E.J. Fisher, G.T. Peng, J.S. Hodges, J. Chesnut, and C.C. Child A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS Clin Infect Dis 29 1999 125 133
15. J.N. Cohn, M.A. Pfeffer, J. Rouleau, N. Sharpe, K. Swedberg, and M. Straub Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON) Eur J Heart Fail 5 2003 659 667
16. J.E. Feinberg, S. Hurwitz, D. Cooper, F.R. Sattler, R.R. MacGregor, and W. Powderly A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group J Infect Dis 177 1998 48 56
17. P.E. Goss, J.N. Ingle, S. Martino, N.J. Robert, H.B. Muss, and M.J. Piccart A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 349 2003 1793 1802
18. J. Hitti, L.M. Frenkel, A.M. Stek, S.A. Nachman, D. Baker, and A. Gonzalez-Garcia Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022 J Acquir Immune Defic Syndr 36 2004 772 776
19. L. Holmberg, and H. Anderson HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped Lancet 363 2004 453 455 (Pubitemid 38210063)
20. M.A. Jacobson, C.L. Besch, C. Child, R. Hafner, J.P. Matts, and K. Muth Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDS Lancet 339 1992 333 334
21. N. Ting Introduction and new drug development process dose finding in drug development 2006 Springer New York p. 1-17